Quadrant Capital Group’s Verastem VSTM Stock Holding History

Quadrant Capital Group’s Portfolio VSTM Stock Details VSTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-7	Closed	-$38	–	2563
2026 Q1	$38	Buy	+7	New	+$43	﹤0.01%	2702

Other funds holding VSTM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Quadrant Capital Group's VSTM Position: Q2 2026 in Review

Quadrant Capital Group sold out of Verastem (VSTM) in Q2 2026, closing a stake of 7 shares — an estimated $38 sold.

Quadrant Capital Group first reported a position in VSTM in Q1 2026 and held it in 1 quarter. The position peaked at $38 in Q1 2026. 157 funds tracked by Wall St. Rank hold VSTM as of Q2 2026.

Quadrant Capital Group reported no remaining Verastem position as of Q2 2026 after selling out during the quarter.
Quadrant Capital Group sold 7 Verastem shares in Q2 2026, an estimated $38.
Quadrant Capital Group first reported a position in Verastem in Q1 2026 and held it in 1 quarter.
Quadrant Capital Group's Verastem position peaked at $38 in Q1 2026.
157 funds tracked by Wall St. Rank held Verastem as of Q2 2026.

Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.